Vicky Kaushal shared his first official meet with Katrina Kaif, and how their love bloomed through a series of random and unplanned encounters.

A ceasefire in eastern Democratic Republic of Congo doesn't appear to be holding, deputy U.N. envoy in Congo Vivian van de ...

Residents in the eastern city of Bukavu pray for peace as fighting with Rwandan backed rebels bereaks out with renewed intensity in the Democratic Republic of Congo.

Oprah Winfrey is sharing new details on her weight loss in recent years, including the kind of weight loss drug she took. In a recent episode of "The Oprah Podcast", she said that she took a GLP-1 ...

JavaScript is disabled in your web browser or browser is too old to support JavaScript. Today almost all web pages contain JavaScript, a scripting programming language that runs on visitor's web ...

Zomato CEO Deepinder Goyal with ex-wife Kanchan Joshi ... Trump Meme Coin investors suffer heavy loss as its value falls to less than…, all-time high was… Mukesh Ambani and Nita Ambani ...

She showed off her new look and shocked fans Throughout her health journey, her fans seemed to notice her weight loss more than she did. “I don’t really see it because if anyone who’s on a ...

In a letter to restaurant partners, Zomato CEO Deepinder Goyal said Bistro is not an existential threat to the restaurant industry. “Bistro is not a ‘private label’ or ‘Zomato kitchen.’ In the past, I ...

Zomato’s instant food delivery app Bistro is not a “private label” and will not compete with restaurants, said Deepinder Goyal, the startup’s founder and chief executive officer, seeking to reassure ...

Deepinder Goyal has written to restaurants over their concerns of 10-minute delivery stating that Zomato is not competing with restaurants, and that Bistro is not a “private label" or "Zomato kitchen.

Amidst rising concerns about 10-minute food deliveries, Zomato founder and CEO Deepinder Goyal told the company’s restaurant partners that Zomato as a restaurant aggregator will “never compete ...

There’s a huge range, no one knows what it could be.” The first of a new generation of GLP-1 drugs was approved for weight loss in the US in 2021, but lack of manufacturing capacity means ...